Learn More
Cayman Chemical LasofoxIfen 10mg

Supplier: Cayman Chemical 2175410 MG
A selective estrogen receptor modulator, selectively binds to human ERα (IC50 = 1.5 nM); inhibits bone loss in ovariectomized rats; in clinical studies 0.5 mg/day associated with reduced risks of nonvertebral and vertebral fractures, ER-positive breast cancer, coronary heart disease, and stroke and increased risk of venous thromboembolic events; an inverse agonist at the CB2 cannabinoid receptor
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.